Back

Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?

European Heart Journal

18 August 2022
Organised by: Logo
Read full article
ESC Journals

Contributors

Bertram Pitt
Bertram Pitt

Author

Deepak L Bhatt
Deepak L Bhatt

Author

Icahn School of Medicine at Mount Sinai New York City , United States of America

Marco Metra
Marco Metra

Author

IRCCS San Raffaele Scientific Institute Milan , Italy

You may be interested in
thumbnail
Congress Presentation
Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction
29 August 2020
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources